Ryan B Barlow, DO
Family Practice · Downey
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 13 years
- Graduated 2013
Offices
4 locations · Ame Medical Group Inc · 2 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barlow’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C14110 · Cancelled
Licence status: Cancelled · since 1952 · University of Cincinnati College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$97,878
Medicare paid this office $97,878 for 489 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 317 | $64,001 | $119 |
| New patient visit (60+ min) | 138 | $23,082 | $167 |
| New patient visit (30+ min) | 35 | $2,184 | $62 |
| Short return visit (20+ min) | 32 | $1,730 | $43 |
| Removal of impacted ear wax | 11 | $422 | $38 |
See all 13 services
| Long return visit (40+ min) | 317 | $64,001 | $119 |
| New patient visit (60+ min) | 138 | $23,082 | $167 |
| New patient visit (30+ min) | 35 | $2,184 | $62 |
| Short return visit (20+ min) | 32 | $1,730 | $43 |
| Removal of impacted ear wax | 11 | $422 | $38 |
| Urinalysis, manual test | 97 | $402 | $3 |
| X-ray of chest, 2 views | 30 | $281 | $9 |
| Insertion of needle into vein for collection of blood sample | 24 | $234 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 24 | $87 | $3 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $81 | $7 |
| X-ray of knee, 3 views | 11 | $76 | $7 |
| X-ray of foot, minimum of 3 views | 13 | $67 | $5 |
| Blood count, hemoglobin | 17 | $42 | $2 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Removal of impacted ear wax | – | – | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
489 Original Medicare patients in 2024. Average age 67 · Under 65 27% · 85 and older 9% · Women 67% · Also on Medicaid 80% · Health risk score 1.38. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Diabetes 44% · Chronic kidney disease 21% · Depression 19% · Coronary heart disease 15% · Heart failure 15% · COPD 12% · Dementia 10% · Cancer 8% · Atrial fibrillation 8% · Stroke 7%.
The office billed $330,636, Medicare allowed $150,487 and paid $97,878; for 1,166 services of 58 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 489 | 1,166 | 67 | 1.38 | $330,636 | $97,878 |
| 2023 | 565 | 1,328 | 67 | 1.47 | $365,336 | $109,129 |
| 2022 | 200 | 307 | 65 | 1.32 | $94,174 | $33,307 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 462 | $89,500 | $119 |
| Short return visit (20+ min) | 81 | $6,806 | $74 |
| New patient visit (30+ min) | 71 | $5,941 | $84 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 40 | $1,523 | $35 |
| Urinalysis, manual test | 105 | $423 | $3 |
| X-ray of chest, 2 views | 23 | $229 | $8 |
| Insertion of needle into vein for collection of blood sample | 18 | $193 | $8 |
| Blood glucose (sugar) test performed by hand-held instrument | 17 | $74 | $3 |
| X-ray of knee, 3 views | 12 | $69 | $6 |
| X-ray of foot, minimum of 3 views | 11 | $48 | $4 |
2022: 4 services
| Long return visit (40+ min) | 180 | $29,754 | $142 |
| New patient visit (30+ min) | 16 | $1,654 | $103 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 16 | $554 | $35 |
| Urinalysis, manual test | 25 | $85 | $3 |
Medicaid work
$26,155 in 2024
Medicaid paid $26,155 for 3,856 billed services this clinician did in 2024, up to 169 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 573 | $11,517 |
| New patient visit (30+ min) | 286 | $6,153 |
| Long return visit (40+ min) | 170 | $4,983 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 63 | $2,325 |
| Short return visit | 50 | $1,128 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 121 | $47 |
| BODY MASS INDEX DOCD | 968 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 706 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 75 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 24 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 576 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 217 | $0 |
| 2024 | 3,856 | 13 | 169 | $26,155 |
| 2023 | 32,418 | 35 | 1,825 | $299,227 |
| 2022 | 25,678 | 26 | 1,941 | $232,008 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 3,859 | $127,697 |
| New patient visit (30+ min) | 3,891 | $83,244 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 1,092 | $47,883 |
| Long return visit (40+ min) | 316 | $11,696 |
| BODY MASS INDEX DOCD | 7,451 | $6,348 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 5,282 | $5,027 |
| SARSCOV CORONAVIRUS AG IA | 283 | $4,597 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 309 | $3,358 |
| Return visit (30+ min) | 61 | $2,990 |
| Short return visit | 123 | $1,855 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 895 | $961 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 4,094 | $599 |
2022
| Short return visit (20+ min) | 3,489 | $107,481 |
| New patient visit (30+ min) | 2,975 | $66,769 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 750 | $32,052 |
| SARSCOV CORONAVIRUS AG IA | 477 | $6,792 |
| BODY MASS INDEX DOCD | 5,951 | $4,448 |
| Long return visit (40+ min) | 78 | $2,787 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 4,091 | $2,755 |
| Return visit (30+ min) | 54 | $2,430 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 304 | $2,169 |
| Short return visit | 101 | $1,608 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 534 | $769 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 1,605 | $360 |
Drugs they prescribed that Part D paid
$26,073
Pharmacies billed $26,073 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
719 generic and fewer than 11 brand-name prescriptions · $26,073 in drug cost · 253 antibiotic prescriptions to 239 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 56 | $1,557 | $26 |
| Promethazine | 41 | $414 | $10 |
| Methylprednisolone | 77 | $319 | $4 |
| Fluticasone Propionate | 16 | $238 | $10 |
| Azithromycin | 83 | $197 | $2 |
See all 16 drugs
| Albuterol Sulfate Hfa | 56 | $1,557 | $26 |
| Promethazine | 41 | $414 | $10 |
| Methylprednisolone | 77 | $319 | $4 |
| Fluticasone Propionate | 16 | $238 | $10 |
| Azithromycin | 83 | $197 | $2 |
| Nitrofurantoin Mono-Macro | 35 | $189 | $5 |
| Cephalexin | 27 | $135 | $5 |
| Ibuprofen | 33 | $127 | $4 |
| Amoxicillin-Clavulanate Potass | 18 | $70 | $4 |
| Amoxicillin | 31 | $66 | $2 |
| Sulfamethoxazole-Trimethoprim | 28 | $50 | $2 |
| Omeprazole | 12 | $48 | $3 |
| Triamcinolone Acetonide | 11 | $45 | $4 |
| Naproxen | 21 | $43 | $2 |
| Ciprofloxacin | 15 | $31 | $2 |
| Cyclobenzaprine | 15 | $26 | $2 |
Year by year
| 2024 | 814 | 391 | None | None | $26,073 |
| 2023 | 458 | 264 | None | None | $13,194 |
| 2022 | 163 | 103 | None | 7% | $4,493 |
| 2021 | 141 | 68 | None | None | $5,812 |
| 2020 | 216 | 119 | None | 8% | $3,891 |
| 2019 | 313 | 185 | None | 9% | $17,073 |
| 2018 | 200 | 147 | None | 12% | $14,423 |
| 2017 | 110 | 59 | 0% (0) | None | $2,134 |
| 2016 | 87 | 15 | 0% (0) | 31% | $6,580 |
| 2015 | 101 | 17 | 0% (0) | 41% | $7,641 |
| 2014 | 11 | None | 0% (0) | None | $1,477 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Albuterol Sulfate Hfa | 26 | $1,151 | $44 |
| Nitrofurantoin Mono-Macro | 21 | $385 | $18 |
| Methylprednisolone | 29 | $288 | $10 |
| Azithromycin | 49 | $211 | $4 |
| Metformin | 13 | $186 | $14 |
| Cephalexin | 21 | $179 | $9 |
| Promethazine | 12 | $150 | $12 |
| Fluticasone Propionate | 11 | $146 | $13 |
| Ibuprofen | 26 | $122 | $5 |
| Ciprofloxacin | 13 | $80 | $6 |
| Triamcinolone Acetonide | 11 | $56 | $5 |
| Naproxen | 12 | $42 | $3 |
| Cyclobenzaprine | 13 | $40 | $3 |
2022: 5 drugs
| Promethazine | 14 | $155 | $11 |
| Fluticasone Propionate | 12 | $114 | $10 |
| Azithromycin | 15 | $63 | $4 |
| Amoxicillin | 13 | $61 | $5 |
| Ibuprofen | 11 | $47 | $4 |
2020: 2 drugs
| Promethazine | 12 | $49 | $4 |
| Amoxicillin | 12 | $48 | $4 |
2019: 7 drugs
| Promethazine | 37 | $223 | $6 |
| Nitrofurantoin Mono-Macro | 14 | $220 | $16 |
| Fluticasone Propionate | 17 | $190 | $11 |
| Azithromycin | 27 | $177 | $7 |
| Naproxen | 20 | $97 | $5 |
| Amoxicillin | 21 | $81 | $4 |
| Ibuprofen | 14 | $56 | $4 |
2018: 4 drugs
| Nitrofurantoin Mono-Macro | 14 | $216 | $15 |
| Azithromycin | 27 | $200 | $7 |
| Ciprofloxacin | 18 | $169 | $9 |
| Promethazine | 17 | $104 | $6 |
2016: 3 drugs
| Janumet | 14 | $2,548 | $182 |
| Atorvastatin | 11 | $136 | $12 |
| Hydrochlorothiazide | 12 | $122 | $10 |
2015: 1 drug
| Janumet | 24 | $4,226 | $176 |
Money from drug and device companies
$46 in 2025
| 2025 | 2 | 2 | None | $46 |
| 2022 | 1 | 1 | None | $28 |
| 2021 | 1 | 3 | None | $51 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $24 | 1 payment
|
| Pfizer | Paxlovid | $22 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-11-13 | Paxlovid | $22 |
| Sanofi-Aventis U.S. | Meals · 2025-03-07 | Tzield | $24 |
See earlier years (2022, 2021)
2022: $28
| Boston Scientific | Resonate El Icd Vr | $28 | 1 payment
|
2021: $51
| Genentech USA | Xofluza | $51 | 3 payments
|
Professional record
- NPI
- 1356758346
- Licence
- CA 14110California C14110: Cancelled
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 11942 Paramount Blvd Ste 101, Downey, CA, 90242
- NPI first listed
- 2014-07-22
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.